Literature DB >> 22030369

Subunit approach to evaluation of the immune protective potential of leptospiral antigens.

Samuel R Félix1, Daiane D Hartwig, Ana Paula C Argondizzo, Éverton F Silva, Fabiana K Seixas, Amilton C P Seixas Neto, Marco A Medeiros, Walter Lilenbaum, Odir A Dellagostin.   

Abstract

Leptospirosis is the most widespread zoonosis in the world. Current vaccines are based on whole-cell preparations that cause severe side effects and do not induce satisfactory immunity. In light of the leptospiral genome sequences recently made available, several studies aimed at identification of protective recombinant immunogens have been performed; however, few such immunogens have been identified. The aim of this study was to evaluate 27 recombinant antigens to determine their potential to induce an immune response protective against leptospirosis in the hamster model. Experiments were conducted with groups of female hamsters immunized with individual antigen preparations. Hamsters were then challenged with a lethal dose of Leptospira interrogans. Thirteen antigens induced protective immune responses; however, only recombinant proteins LIC10325 and LIC13059 induced significant protection against mortality. These results have important implications for the development of an efficacious recombinant subunit vaccine against leptospirosis.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22030369      PMCID: PMC3232701          DOI: 10.1128/CVI.05297-11

Source DB:  PubMed          Journal:  Clin Vaccine Immunol        ISSN: 1556-679X


  27 in total

Review 1.  Leptospirosis: a zoonotic disease of global importance.

Authors:  Ajay R Bharti; Jarlath E Nally; Jessica N Ricaldi; Michael A Matthias; Monica M Diaz; Michael A Lovett; Paul N Levett; Robert H Gilman; Michael R Willig; Eduardo Gotuzzo; Joseph M Vinetz
Journal:  Lancet Infect Dis       Date:  2003-12       Impact factor: 25.071

2.  Leptospiral immunoglobulin-like proteins elicit protective immunity.

Authors:  Nobuo Koizumi; Haruo Watanabe
Journal:  Vaccine       Date:  2004-03-29       Impact factor: 3.641

Review 3.  Leptospira: the dawn of the molecular genetics era for an emerging zoonotic pathogen.

Authors:  Albert I Ko; Cyrille Goarant; Mathieu Picardeau
Journal:  Nat Rev Microbiol       Date:  2009-10       Impact factor: 60.633

4.  Targeted mutagenesis in pathogenic Leptospira species: disruption of the LigB gene does not affect virulence in animal models of leptospirosis.

Authors:  Julio Croda; Claudio Pereira Figueira; Elsio A Wunder; Cleiton S Santos; Mitermayer G Reis; Albert I Ko; Mathieu Picardeau
Journal:  Infect Immun       Date:  2008-09-22       Impact factor: 3.441

5.  Characterization of the immunogenic and antigenic potential of putative lipoproteins from Leptospira interrogans.

Authors:  Daiane D Hartwig; Fabiana K Seixas; Gustavo M Cerqueira; Alan J A McBride; Odir A Dellagostin
Journal:  Curr Microbiol       Date:  2011-01-11       Impact factor: 2.188

6.  Identification of the hemolysis-associated protein 1 as a cross-protective immunogen of Leptospira interrogans by adenovirus-mediated vaccination.

Authors:  C Branger; C Sonrier; B Chatrenet; B Klonjkowski; N Ruvoen-Clouet; A Aubert; G André-Fontaine; M Eloit
Journal:  Infect Immun       Date:  2001-11       Impact factor: 3.441

7.  Protection against Leptospira interrogans sensu lato challenge by DNA immunization with the gene encoding hemolysin-associated protein 1.

Authors:  C Branger; B Chatrenet; A Gauvrit; F Aviat; A Aubert; J M Bach; G André-Fontaine
Journal:  Infect Immun       Date:  2005-07       Impact factor: 3.441

8.  A high-copy T7 Escherichia coli expression vector for the production of recombinant proteins with a minimal N-terminal His-tagged fusion peptide.

Authors:  C R R Ramos; P A E Abreu; A L T O Nascimento; P L Ho
Journal:  Braz J Med Biol Res       Date:  2004-07-20       Impact factor: 2.590

9.  Recombinant Mycobacterium bovis BCG expressing the LipL32 antigen of Leptospira interrogans protects hamsters from challenge.

Authors:  Fabiana Kömmling Seixas; Everton Fagonde da Silva; Daiane Drawanz Hartwig; Gustavo Maia Cerqueira; Marta Amaral; Michel Quevedo Fagundes; Robson Grando Dossa; Odir Antônio Dellagostin
Journal:  Vaccine       Date:  2007-11-12       Impact factor: 3.641

Review 10.  Leptospira and leptospirosis.

Authors:  Ben Adler; Alejandro de la Peña Moctezuma
Journal:  Vet Microbiol       Date:  2009-03-13       Impact factor: 3.293

View more
  10 in total

1.  A prime-boost strategy using the novel vaccine candidate, LemA, protects hamsters against leptospirosis.

Authors:  Daiane D Hartwig; Karine M Forster; Thaís L Oliveira; Marta Amaral; Alan J A McBride; Odir A Dellagostin
Journal:  Clin Vaccine Immunol       Date:  2013-03-20

2.  Protection against lethal leptospirosis after vaccination with LipL32 coupled or coadministered with the B subunit of Escherichia coli heat-labile enterotoxin.

Authors:  André A Grassmann; Samuel R Félix; Carolina Ximendes dos Santos; Marta G Amaral; Amilton C P Seixas Neto; Michel Q Fagundes; Fabiana K Seixas; Everton F da Silva; Fabricio R Conceição; Odir A Dellagostin
Journal:  Clin Vaccine Immunol       Date:  2012-02-29

3.  Features of two proteins of Leptospira interrogans with potential role in host-pathogen interactions.

Authors:  Renan F Domingos; Monica L Vieira; Eliete C Romero; Amane Paldes Gonçales; Zenaide M de Morais; Silvio A Vasconcellos; Ana L T O Nascimento
Journal:  BMC Microbiol       Date:  2012-03-30       Impact factor: 3.605

4.  Evaluation of pre-induction temperature, cell growth at induction and IPTG concentration on the expression of a leptospiral protein in E. coli using shaking flasks and microbioreactor.

Authors:  Ariane Leites Larentis; Júlia Fabiana Monteiro Quintal Nicolau; Gabriela dos Santos Esteves; Daniel Tait Vareschini; Fernanda Vicente Ribeiro de Almeida; Mitermayer Galvão dos Reis; Ricardo Galler; Marco Alberto Medeiros
Journal:  BMC Res Notes       Date:  2014-09-25

5.  Induction of boosted immune response in mice by leptospiral surface proteins expressed in fusion with DnaK.

Authors:  Marina V Atzingen; Dunia Rodriguez; Gabriela Hase Siqueira; Luciana C C Leite; Ana L T O Nascimento
Journal:  Biomed Res Int       Date:  2014-07-06       Impact factor: 3.411

6.  MAT cross-reactions or vaccine cross-protection: retrospective study of 863 leptospirosis canine cases.

Authors:  Geneviève André-Fontaine; Laetitia Triger
Journal:  Heliyon       Date:  2018-11-02

7.  Evaluation of immunoprotective activity of six leptospiral proteins in the hamster model of leptospirosis.

Authors:  Marina V Atzingen; Mônica L Vieira; Rosane Oliveira; Renan F Domingos; Renata S Mendes; Aline T Barros; Amane P Gonçales; Zenaide M de Morais; Silvio A Vasconcellos; Ana Lto Nascimento
Journal:  Open Microbiol J       Date:  2012-10-19

8.  Xanthan gum as an adjuvant in a subunit vaccine preparation against leptospirosis.

Authors:  Katia L Bacelo; Daiane D Hartwig; Fabiana K Seixas; Rodrigo Schuch; Angelita da S Moreira; Marta Amaral; Tiago Collares; Claire T Vendrusculo; Alan J A McBride; Odir A Dellagostin
Journal:  Biomed Res Int       Date:  2014-05-07       Impact factor: 3.411

9.  DNA prime-protein boost based vaccination with a conserved region of leptospiral immunoglobulin-like A and B proteins enhances protection against leptospirosis.

Authors:  Karine M Forster; Daiane D Hartwig; Thaís L Oliveira; Kátia L Bacelo; Rodrigo Schuch; Marta G Amaral; Odir A Dellagostin
Journal:  Mem Inst Oswaldo Cruz       Date:  2015-12-11       Impact factor: 2.743

10.  COMPARISON OF 16S rRNA-PCR-RFLP, LipL32-PCR AND OmpL1-PCR METHODS IN THE DIAGNOSIS OF LEPTOSPIROSIS.

Authors:  Tülin Güven Gökmen; Ayben Soyal; Yıldız Kalayci; Cansu Önlen; Fatih Köksal
Journal:  Rev Inst Med Trop Sao Paulo       Date:  2016-09-22       Impact factor: 1.846

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.